Key Insights into the Real-Time PCR, Digital PCR And End-Point PCR Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theReal-Time PCR, Digital PCR And End-Point PCR Market?
The rise in infectious diseases is anticipated to fuel the expansion of the real-time PCR, digital PCR, and end-point PCR markets. Infectious diseases are disorders produced by the intrusion and proliferation of harmful microorganisms like bacteria, viruses, fungi, and parasites. Techniques such as real-time PCR, digital PCR, and end-point PCR are employed in infectious diseases for specific pathogen quantification or their genetic content, tracking disease development, and swift detection of infections like HIV, hepatitis, respiratory viruses, and tuberculosis. For example, in July 2023, as stated by UNAIDS, the UN program based in Switzerland committed to combating the worldwide HIV/AIDS epidemic, the global count of people living with HIV reached 39 million in 2022, marking a 3.17% increase from 37.7 million in 2020. Besides, approximately 1.3 million fresh HIV infections were recorded in 2022. In addition, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health institute, there were 8,300 tuberculosis (TB) cases reported in the United States in 2022, an increase from 7,874 cases in 2021. As a result, the amplifying incidence of infectious diseases is expected to stimulate the expansion of the cephalosporin market. PCR technologies are shown to be positioned for growth induced by the surge in chronic diseases which are expected to spur the growth of the real-time PCR, digital PCR, and end-point PCR markets. Chronic diseases are persistent health problems that linger for a long period that frequently escalate over time. Real-time PCR is applied for the prompt and precise diagnosis of chronic diseases. It enables medical professionals to identify specific DNA or RNA markers related to chronic conditions such as cancer, diabetes, and viral infections. For instance, in September 2022, according to the World Health Organization, a specialized agency based in Switzerland stated that out of 41 million deaths annually worldwide, 74% are caused by non-communicable diseases (NCDs) or chronic diseases. These include 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the escalation in chronic diseases is propelling the expansion of the real-time PCR, digital PCR, and end-point PCR market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
#What Growth Opportunities Will Drive the Real-Time PCR, Digital PCR And End-Point PCR Market’s CAGR Through 2034?
In recent times, there has been strong growth in the real-time PCR, digital PCR, and end-point PCR market size. Projected growth is from $38.37 billion in 2024 to $41.88 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 9.2%. Factors contributing to the surge during the historic period include standardizing PCR protocols, its importance in personalized medicine, role in drug discovery and development, and its use in forensic and paternity tests.
The market size for real-time pcr, digital pcr, and end-point pcr is anticipated to experience robust growth over the coming years. By 2029, it is projected to reach $60.91 billion with a compound annual growth rate (CAGR) of 9.8%. The projected growth throughout this period is linked to the expansion of molecular diagnostics, increased infectious disease testing, growing demand for genetic testing, as well as market penetration in research and forensics, and the rapid development of point-of-care PCR solutions. Key trends predicted to influence the market throughout this period include the rising popularity of digital assays, advancements in multiplex PCR, a shift towards digital PCR technology, the introduction of automation and high-throughput systems, and the miniaturization of PCR platforms.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296
Which Upcoming Market Trends and Innovations Are Set to Influence theReal-Time PCR, Digital PCR And End-Point PCR Market’s Path Forward?
Leading corporations in the sectors of real-time PCR, digital PCR, and end-point PCR markets are pioneering unique products by leveraging state-of-the-art technologies like digital polymerase chain reaction (dPCR) technology. This method enhances the understanding of a patient’s cancer, genetic disorder, or infectious disease. dPCR technology, a refined version of traditional polymerase chain reaction (PCR) techniques, allows the direct quantification and clonal amplification of various types of nucleic acid strands like DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, an American medicine and medical devices producer, introduced their latest digital PCR system, the Digital LightCycler System, designed for the early diagnosis and intervention of different chronic and genetic diseases. The system automates workflow and data management, removing the reliance on external calculations, software, and processors. It offers high sensitivity and precision through a blend of three nano well plate configurations, six superior optical channels, and 5x concentrated DNA and RNA master mixes. The Digital LightCycler System increases the value of Roche’s suite of diagnostic platforms through its advanced technology, potential clinical uses, adaptability, and automation of workflows.
Who Are the Dominant Market Players Pushing the Boundaries of theReal-Time PCR, Digital PCR And End-Point PCR Market?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Real-Time PCR, Digital PCR And End-Point PCR Market, and How Do They Contribute to Growth?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations
Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp
What Regions Are Dominating the Real-Time PCR, Digital PCR And End-Point PCR Market Growth?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Real-Time PCR, Digital PCR And End-Point PCR Market 2025, By The Business Research Company:
PCR And Realtime PCR Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
Location-Based Services (LBS) And Real-Time Location Systems (RTLS) Global Market Report 2024
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
